-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Sepsis is a potentially life-threatening disease caused by tissue and organ damage caused by the body's overreaction to infection
Recently, researchers at Nagoya University and their colleagues found that a large decrease in platelets, rather than an abnormally low platelet count, increases the risk of death from sepsis
It is well known that during sepsis, a serious blood disease called disseminated intravascular coagulation (DIC) can form tiny blood clots in the bloodstream, resulting in thrombocytopenia
At the same time, there is a theory that in sepsis-related DIC, the main influence on the risk of death is the degree of platelet depletion (rapid decline), rather than the absolute platelet count
In this context, researchers from Nagoya University and their colleagues conducted a study to study the importance of thrombocytopenia on the mortality of sepsis.
The results showed that the degree of thrombocytopenia was related to the risk of death related to sepsis, but not to the absolute platelet count, indicating that the risk of death is higher when the platelet count drops rapidly
The researchers concluded that compared with the absolute platelet count, the degree of thrombocytopenia may be a more reasonable standard for assessing the risk of death from DIC related to sepsis
Original title:
Relative platelet reductions provide better pathophysiologic signatures of coagulopathies in sepsis
DOI
s41598-021-93635-5